Comparison between Alkosign IPO and Fabino Life Sciences IPO.
IPO Details
Alkosign IPO is a SME Fixed Price IPO proposed to list at BSE SME while Fabino Life Sciences IPO is a SME Fixed Price proposed to list at BSE SME.
Issue Size and Price
The total issue size of Alkosign IPO is up to ₹11.53 Cr whereas the issue size of the Fabino Life Sciences IPO is up to ₹3.07 Cr. The final issue price of Alkosign IPO is ₹45.00 per share and of Fabino Life Sciences IPO is ₹36.00 per share.
IPO Timetable
Alkosign IPO opens on Jan 18, 2022, while Fabino Life Sciences IPO opens on Dec 31, 2021. The closing date of Alkosign IPO and Fabino Life Sciences IPO is Jan 21, 2022, and Jan 05, 2022, respectively.
| | Alkosign IPO | Fabino Life Sciences IPO |
|---|
| Issue Open | Jan 18, 2022 | Dec 31, 2021 |
| Issue Close | Jan 21, 2022 | Jan 05, 2022 |
| Basis Of Allotment (Tentative) | Jan 27, 2022 | Jan 10, 2022 |
| Initiation of Refunds (Tentative) | Jan 28, 2022 | Jan 11, 2022 |
| Credit of Share (Tentative) | Jan 28, 2022 | Jan 12, 2022 |
| Listing date (Tentative) | Feb 01, 2022 | Jan 13, 2022 |
Financials & KPIs
Alkosign IPO P/E ratio is , as compared to Fabino Life Sciences IPO P/E ratio of 133.
Shares Offered
In the Alkosign IPO Retail Individual Investors (RII) are offered 12,81,000 shares while in Fabino Life Sciences IPO retail investors are offered 12,81,000 shares. Qualified Institutional Buyers (QIB) are offered in Alkosign IPO and in Fabino Life Sciences IPO.
| | Alkosign IPO | Fabino Life Sciences IPO |
|---|
| Market Maker Reservation | 1,38,000 shares | 48,000 shares |
| NII | 12,81,000 shares | 4,26,000 shares |
| RII | 12,81,000 shares | 4,26,000 shares |
| Total | 25,62,000 shares | 8,52,000 shares |
Bids Received (Subscription)
Alkosign IPO subscribed 4.76x in total, whereas Fabino Life Sciences IPO subscribed 6.93x.
